BCL2 and lung carcinoma: In this study, we revealed that ZQT played an immunomodulatory role in an orthotopic lung cancer mouse model via reducing the population of G-MDSCs and inhibiting their immunosuppressive activity in TME by activating the STAT3/Bcl-2/caspase-3 signaling pathway.